| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 45,406 shares
@ $0
Paid exercise price by delivering 12,547 shares
@ $0.5965, valued at
$7.5k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Sold 35,453 shares
@ $0.5978, valued at
$21.2k
Granted 250,000 shares
@ $0 |
|
| 07/20/2022 |
4
| ANIDO ARMANDO (Chairman & CEO) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 43,164 shares
@ $0
Sold 11,899 shares
@ $1.1, valued at
$13.1k
|
|
| 06/22/2022 |
4
| ANIDO ARMANDO (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 10,000 options to buy
@ $1.78, valued at
$17.8k
|
|
| 01/28/2022 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 120,000 shares
@ $0
Granted 190,000 options to buy
@ $2.41, valued at
$457.9k
|
|
| 06/21/2021 |
4
| ANIDO ARMANDO (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 10,000 options to buy
@ $7.51, valued at
$75.1k
|
|
| 03/31/2021 |
4/A
| ANIDO ARMANDO (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 55,000 options to buy
@ $0.73, valued at
$40.2k
|
|
| 01/25/2021 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 107,911 shares
@ $0
Granted 161,867 options to buy
@ $3.58, valued at
$579.5k
|
|
| 12/23/2020 |
4
| ANIDO ARMANDO (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Bought 5,000 shares
@ $6.25, valued at
$31.3k
Granted 2,500 warrants
@ $7.33, valued at
$18.3k
Granted 2,500 warrants
@ $8.25, valued at
$20.6k
|
|
| 07/08/2020 |
4
| ANIDO ARMANDO (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 45,000 options to buy
@ $0.73, valued at
$32.9k
|
|
| 02/03/2020 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 162,480 options to buy
@ $5.05, valued at
$820.5k
|
|
| 06/20/2019 |
4
| ANIDO ARMANDO (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 45,000 options to buy
@ $1.29, valued at
$58.1k
|
|
| 01/30/2019 |
4/A
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 160,000 options to buy
@ $3.65, valued at
$584k
|
|
| 01/28/2019 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 160,000 options to buy
@ $3.65, valued at
$584k
|
|
| 01/23/2019 |
4
| ANIDO ARMANDO (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 70,000 options to buy
@ $0.7425, valued at
$52k
|
|
| 01/23/2019 |
3
| ANIDO ARMANDO (Director) has filed a Form 3 on SCYNEXIS INC |
| 08/07/2018 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Bought 15,000 shares
@ $5.9615, valued at
$89.4k
|
|
| 01/16/2018 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 81,000 options to buy
@ $11.71, valued at
$948.5k
|
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2017 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Bought 3,500 shares
@ $19.76, valued at
$69.2k
Bought 1,500 shares
@ $19.57, valued at
$29.4k
|
|
| 01/26/2017 |
4
| ANIDO ARMANDO (Chairman & Chief Exec Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc. |
| 05/13/2016 |
4
| ANIDO ARMANDO (Director) has filed a Form 4 on Aviragen Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.5, valued at
$30k
|
|
| 10/21/2015 |
4
| ANIDO ARMANDO (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.95, valued at
$68.3k
|
|
| 08/10/2015 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Converted 26,595 shares
@ $0
Converted 13,297 shares
@ $0
Converted 50,000 options to buy
@ $0
Converted 25,000 options to buy
@ $0 |
|
| 08/06/2015 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 396,678 options
@ $14, valued at
$5.6M
|
|
| 02/25/2014 |
4
| ANIDO ARMANDO (CEO) has filed a Form 4 on NUPATHE INC.|
Txns:
| Disposed/sold 1,270,000 shares
@ $6.8, valued at
$8.6M
|
|
| 01/22/2013 |
4
| ANIDO ARMANDO (CEO) has filed a Form 4 on NUPATHE INC.|
Txns:
| Granted 317,580 shares
@ $0 |
|
| 01/09/2013 |
4
| ANIDO ARMANDO (CEO) has filed a Form 4 on NUPATHE INC.|
Txns:
| Granted 369,095 shares
@ $0
Disposed/sold 738,190 options to buy
@ $3.81, valued at
$2.8M
|
|
| 01/03/2013 |
4
| ANIDO ARMANDO (CEO) has filed a Form 4 on NUPATHE INC.|
Txns:
| Granted 466,660 shares
@ $0
Granted 116,665 shares
@ $0 |
|
| 07/27/2012 |
4
| ANIDO ARMANDO (CEO) has filed a Form 4 on NUPATHE INC.|
Txns:
| Granted 738,190 options to buy
@ $3.81, valued at
$2.8M
|
|
| 07/27/2012 |
3
| ANIDO ARMANDO (CEO) has filed a Form 3 on NUPATHE INC. |
| 12/08/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|